Income Statement Jaguar Health, Inc.

Equities

JAGX

US47010C8881

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 02:30:00 22/01/2026 am IST			5-day change	1st Jan Change
0.8091 ^USD	-5.37%		+5.86%	-13.11%

16/01	Jaguar Health Inc - Co & unit entered license agreement with Woodward Specialty LLC - SEC filing	RE
06/01	Jaguar Health, Inc. announced that it has received $0.35 million in funding	CI

b1559e47673b4fd306b9c0c599afb9b.PiSYSU9Zt2i8Gb8p2dmP1jsIj_U7X5VJHvmh2ewGFxM.aX7SIRAP-AH_XuxegO37jFJfvpRoErh_J43Srr53WHtxHdcqBzfQUNpg5g

Published financial data: JAGUAR HEALTH, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	93.85L	43.35L	1.2Cr	97.61L	1.17Cr
Total Revenues	93.85L	43.35L	1.2Cr	97.61L	1.17Cr
Cost of Goods Sold, Total	32.8L	23.33L	20.19L	20.37L	19.55L
Gross Profit	61.05L	20.02L	99.37L	77.24L	97.34L
Selling General & Admin Expenses, Total	2.1Cr	2.6Cr	2.67Cr	2.3Cr	2.4Cr
R&D Expenses	64.13L	1.51Cr	1.76Cr	1.86Cr	1.65Cr
Other Operating Expenses, Total	2.74Cr	4.11Cr	4.44Cr	4.16Cr	4.06Cr
Operating Income	-2.13Cr	-3.91Cr	-3.44Cr	-3.39Cr	-3.08Cr
Interest Expense, Total	-27.92L	-84.21L	-1.27Cr	-63.82L	-2L
Net Interest Expenses	-27.92L	-84.21L	-1.27Cr	-63.82L	-2L
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	-25.06L	-27.18L	9L	-49.25L	-94.34L
EBT, Excl. Unusual Items	-2.66Cr	-5.02Cr	-4.62Cr	-4.52Cr	-4.05Cr
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-	-	-	-4L	-
Insurance Settlements	-	-	-	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-72.07L	-23.87L	-21.87L	36.97L	12.45L
EBT, Incl. Unusual Items	-3.38Cr	-5.26Cr	-4.84Cr	-4.19Cr	-3.93Cr
Income Tax Expense	-	-	-	-	-
Earnings From Continuing Operations	-3.38Cr	-5.26Cr	-4.84Cr	-4.19Cr	-3.93Cr
Net Income to Company	-3.38Cr	-5.26Cr	-4.84Cr	-4.19Cr	-3.93Cr
Minority Interest	-	-	9L	6L	8L
Net Income - (IS)	-3.38Cr	-5.26Cr	-4.75Cr	-4.13Cr	-3.85Cr
Preferred Dividend and Other Adjustments	48.39L	-	-	-	-
Net Income to Common Incl Extra Items	-3.86Cr	-5.26Cr	-4.75Cr	-4.13Cr	-3.85Cr
Net Income to Common Excl. Extra Items	-3.86Cr	-5.26Cr	-4.75Cr	-4.13Cr	-3.85Cr
Per Share Items
Net EPS - Basic	-	-	-	-2.69T	-130.69
Basic EPS - Continuing Operations	-	-	-	-2.69T	-130.69
Basic Weighted Average Shares Outstanding	-	-	-	15.38T	3L
Net EPS - Diluted	-	-	-	-2.69T	-130.69
Diluted EPS - Continuing Operations	-	-	-	-2.69T	-130.69
Diluted Weighted Average Shares Outstanding	-	-	-	15.38T	3L
Normalized Basic EPS	-	-	-	-1.8T	-83.36
Normalized Diluted EPS	-	-	-	-1.8T	-83.36
Supplemental Items
EBITDA	-1.96Cr	-3.74Cr	-3.24Cr	-3.19Cr	-2.89Cr
EBITA	-1.96Cr	-3.74Cr	-3.26Cr	-3.19Cr	-2.89Cr
EBIT	-2.13Cr	-3.91Cr	-3.44Cr	-3.39Cr	-3.08Cr
EBITDAR	-1.89Cr	-3.71Cr	-3.18Cr	-3.1Cr	-2.81Cr
Total Revenues (As Reported)	93.85L	-	1.2Cr	-	1.17Cr
Effective Tax Rate - (Ratio)	-	-	-	-	-
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	-	-	-	-	-
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-	-	-	-	-
Normalized Net Income	-1.66Cr	-3.14Cr	-2.79Cr	-2.77Cr	-2.46Cr
Interest on Long-Term Debt	27.92L	84.21L	1.27Cr	63.82L	4L
Supplemental Operating Expense Items
Marketing Expenses	21.87L	34.15L	35.96L	19.03L	24.07L
Selling and Marketing Expenses	66.09L	88.94L	88.37L	64.6L	76.92L
General and Administrative Expenses	1.37Cr	1.68Cr	1.72Cr	1.57Cr	1.55Cr
Research And Development Expense From Footnotes	64.13L	1.51Cr	1.76Cr	1.86Cr	1.65Cr
Net Rental Expense, Total	7L	3L	6L	9L	8L
Imputed Operating Lease Interest Expense	12.96L	8L	19.94L	12.45L	41.01T
Imputed Operating Lease Depreciation	-6L	-6L	-13.65L	-4L	8L
Stock-Based Comp., COGS (Total)	-	-	-	-	-
Stock-Based Comp., R&D Exp. (Total)	7L	13.19L	12.63L	10.44L	7L
Stock-Based Comp., S&M Exp. (Total)	2L	3L	3L	2L	1L
Stock-Based Comp., G&A Exp. (Total)	18.55L	23.36L	17.88L	9L	8L
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	10L	16T	8L	2L	9T
Total Stock-Based Compensation	38.08L	39.9L	41.41L	22.83L	16.5L

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	80.9L	1.71Cr	54.69L	64.69L	80.02L
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	80.9L	1.71Cr	54.69L	64.69L	80.02L
Accounts Receivable, Total	20.98L	17.09L	18.79L	19.67L	15.27L
Other Receivables	28T	4L	6L	2L	1L
Total Receivables	21.26L	21.44L	24.67L	21.84L	16.47L
Inventory	27.82L	49L	70.24L	91.89L	1.03Cr
Prepaid Expenses	23.6L	43.39L	73.61L	1.01Cr	1.22Cr
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	24.34L	-	-	-	-
Total Current Assets	1.78Cr	2.84Cr	2.23Cr	2.8Cr	3.22Cr
Gross Property Plant And Equipment	9L	20.32L	21.01L	21.37L	19.13L
Accumulated Depreciation	-3L	-3L	-4L	-5L	-5L
Net Property Plant And Equipment	7L	17.34L	16.97L	16.72L	14L
Goodwill	-	-	-	-	-
Other Intangibles, Total	2.43Cr	2.27Cr	2.24Cr	2.01Cr	1.85Cr
Other Long-Term Assets, Total	37T	4L	10L	10.12L	13.48L
Total Assets	4.28Cr	5.33Cr	4.75Cr	5.08Cr	5.34Cr
Liabilities
Accounts Payable, Total	47.59L	49.29L	58.08L	49.74L	52.86L
Accrued Expenses, Total	44.93L	71.17L	81.65L	37.98L	19.11L
Short-term Borrowings	-	-	-	-	1L
Current Portion of Long-Term Debt	37.89L	31.84L	1.59Cr	48.67L	1.19Cr
Current Portion of Leases	-	2L	5L	3L	3L
Unearned Revenue Current, Total	-	-	-	-	2L
Other Current Liabilities	2L	1T	-	-	-
Total Current Liabilities	1.32Cr	1.55Cr	3.03Cr	1.4Cr	1.97Cr
Long-Term Debt	1.24Cr	2.5Cr	1.77Cr	3.1Cr	2.35Cr
Long-Term Leases	-	9L	7L	9L	7L
Unearned Revenue Non Current	-	-	-	-	6L
Total Liabilities	2.56Cr	4.14Cr	4.88Cr	4.59Cr	4.44Cr
Preferred Stock Redeemable	-	-	-	-	24.85L
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	24.85L
Common Stock, Total	11T	5T	-	7T	-
Additional Paid In Capital	18Cr	23Cr	27Cr	31Cr	35Cr
Retained Earnings	-17Cr	-22Cr	-27Cr	-31Cr	-35Cr
Comprehensive Income and Other	-	-	-7L	-7L	-5L
Total Common Equity	1.72Cr	1.16Cr	-7L	49.61L	72.85L
Minority Interest	-	2L	-7L	-64T	-8L
Total Equity	1.72Cr	1.19Cr	-13.56L	48.97L	89.79L
Total Liabilities And Equity	4.28Cr	5.33Cr	4.75Cr	5.08Cr	5.34Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	-	-	-	2L	7L
ECS Total Common Shares Outstanding	-	-	-	48.94T	5L
Book Value / Share	-	-	-	101.36	13.79
Tangible Book Value	-71.35L	-1.1Cr	-2.31Cr	-1.52Cr	-1.12Cr
Tangible Book Value Per Share	-	-	-	-309.65	-21.18
Total Debt	1.62Cr	2.94Cr	3.48Cr	3.71Cr	3.65Cr
Net Debt	81.2L	1.23Cr	2.94Cr	3.06Cr	2.85Cr
Debt Equivalent Oper. Leases	55.2L	22.56L	50.32L	70.16L	65.36L
Minority Interest, Total (Incl. Fin. Div)	-	2L	-7L	-64T	-8L
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	13.21L	12.48L	21.01L	20.57L	18.5L
Inventories - Work In Process, Total	10.26L	27.6L	35.99L	65.17L	74.07L
Inventories - Finished Goods, Total	4L	9L	13.24L	6L	10.88L
Inventories - Others	-	-	-	-	-
Land - (BS)	4L	4L	4L	4L	4L
Machinery, Total	5L	5L	5L	5L	5L
Full Time Employees	34	52	60	49	49
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-3.38Cr	-5.26Cr	-4.75Cr	-4.13Cr	-3.85Cr
Depreciation & Amortization - CF	6L	1L	5L	4L	5L
Amortization of Goodwill and Intangible Assets - (CF)	17L	17L	18L	20L	19L
Depreciation & Amortization, Total	22.8L	18.13L	22.92L	23.88L	23.58L
Amortization of Deferred Charges, Total - (CF)	26.7L	51.71L	1.18Cr	1.32Cr	3L
Minority Interest in Earnings - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	4L	-
(Income) Loss On Equity Investments - (CF)	-	-	-	51T	1L
Stock-Based Compensation (CF)	38.08L	39.9L	41.41L	22.83L	16.5L
Other Operating Activities, Total	1.32Cr	43.89L	6L	9L	76.98L
Change In Accounts Receivable	-28.4L	28.23L	-2L	-88T	4L
Change In Inventories	-7L	-21.18L	-21.24L	-21.65L	-11.56L
Change In Accounts Payable	-7L	2L	9L	-9L	3L
Change in Unearned Revenues	-	-	-	-	7L
Change in Other Net Operating Assets	8L	14.04L	-30.36L	-79.91L	-33.45L
Cash from Operations	-1.53Cr	-3.5Cr	-3.31Cr	-3.32Cr	-2.94Cr
Capital Expenditure	-7T	-6T	-77T	-	-16T
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-15.98L	-	-2L
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-7T	-6T	-16.75L	-	-2L
Short Term Debt Issued, Total	-	-	39.75L	-	-
Long-Term Debt Issued, Total	1.94Cr	1.1Cr	-	-	-
Total Debt Issued	1.94Cr	1.1Cr	39.75L	-	-
Short Term Debt Repaid, Total	-	-9L	-11.56L	-9L	-6L
Long-Term Debt Repaid, Total	-72.94L	-19.22L	-1L	-1L	-1L
Total Debt Repaid	-72.94L	-28.65L	-12.56L	-10L	-7L
Issuance of Common Stock	77.56L	3.86Cr	2.06Cr	3.23Cr	3.21Cr
Repurchase of Common Stock	-	-	-	-	-
Issuance of Preferred Stock	-	-	-	6L	-
Other Financing Activities, Total	-3L	-28.53L	-1L	22.15L	-2L
Cash from Financing	1.95Cr	4.39Cr	2.32Cr	3.42Cr	3.12Cr
Foreign Exchange Rate Adjustments	-	-	16T	15T	-54T
Net Change in Cash	42.07L	89.61L	-1.16Cr	10L	15.33L
Supplemental Items
Cash Interest Paid	8L	28T	23T	35T	14T
Levered Free Cash Flow	-88.3L	-1.78Cr	-1.65Cr	-1.72Cr	-1.95Cr
Unlevered Free Cash Flow	-97.55L	-1.77Cr	-2.03Cr	-2.64Cr	-1.96Cr
Change In Net Working Capital	25.21L	-9L	35.43L	98.43L	41.07L
Net Debt Issued / Repaid	1.21Cr	81.6L	27.19L	-10L	-7L

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-33.6	-50.82	-42.71	-43.17	-36.99
Return on Total Capital	-43.27	-65.45	-57.59	-56.18	-44.05
Return On Equity %	-179.03	-362.07	-922.07	-2.37T	-565.74
Return on Common Equity	-295.44	-365.11	-866.42	-1.92T	-628.65
Margin Analysis
Gross Profit Margin %	65.05	46.18	83.11	79.13	83.27
SG&A Margin	223.72	599.7	223.36	236.12	205.52
EBITDA Margin %	-208.6	-861.71	-271.28	-326.88	-247.51
EBITA Margin %	-208.89	-862.15	-272.79	-327.02	-247.51
EBIT Margin %	-227	-901.36	-287.85	-347.51	-263.76
Income From Continuing Operations Margin %	-360.24	-1.21T	-404.78	-429.27	-335.79
Net Income Margin %	-360.24	-1.21T	-396.91	-423.11	-329.3
Net Avail. For Common Margin %	-411.81	-1.21T	-396.91	-423.11	-329.3
Normalized Net Income Margin	-177.16	-723.95	-233.68	-283.43	-210.04
Levered Free Cash Flow Margin	-94.09	-410.18	-137.91	-175.75	-166.56
Unlevered Free Cash Flow Margin	-103.94	-408.06	-169.74	-270.18	-167.67
Asset Turnover
Asset Turnover	0.24	0.09	0.24	0.2	0.22
Fixed Assets Turnover	13.53	3.6	6.97	5.79	7.61
Receivables Turnover (Average Receivables)	4.95	2.28	6.66	5.08	6.69
Inventory Turnover (Average Inventory)	1.34	0.61	0.34	0.25	0.2
Short Term Liquidity
Current Ratio	1.35	1.84	0.74	2	1.63
Quick Ratio	0.77	1.24	0.26	0.62	0.49
Operating Cash Flow to Current Liabilities	-1.16	-2.26	-1.09	-2.38	-1.49
Days Sales Outstanding (Average Receivables)	73.9	160.27	54.77	71.91	54.7
Days Outstanding Inventory (Average Inventory)	274	600.93	1.08T	1.45T	1.83T
Average Days Payable Outstanding	470.46	397.23	472.97	468.28	603.53
Cash Conversion Cycle (Average Days)	-122.56	363.97	659.63	1.06T	1.28T
Long Term Solvency
Total Debt/Equity	94.23	247.74	-2.57T	757.48	406.79
Total Debt / Total Capital	48.52	71.24	104.05	88.34	80.27
LT Debt/Equity	72.21	218.86	-1.36T	650.99	269.4
Long-Term Debt / Total Capital	37.18	62.94	55.17	75.92	53.16
Total Liabilities / Total Assets	59.85	77.75	102.86	90.35	83.19
EBIT / Interest Expense	-7.63	-4.64	-2.7	-5.31	-133.47
EBITDA / Interest Expense	-6.81	-4.4	-2.5	-4.86	-121.71
(EBITDA - Capex) / Interest Expense	-6.82	-4.4	-2.51	-4.86	-121.77
Total Debt / EBITDA	-0.85	-0.79	-1.1	-1.2	-1.3
Net Debt / EBITDA	-0.43	-0.33	-0.92	-0.99	-1.01
Total Debt / (EBITDA - Capex)	-0.85	-0.79	-1.09	-1.2	-1.3
Net Debt / (EBITDA - Capex)	-0.43	-0.33	-0.92	-0.99	-1.01
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	62.51	-53.81	175.8	-18.36	19.75
Gross Profit, 1 Yr. Growth %	211.64	-67.83	396.35	-22.27	26.02
EBITDA, 1 Yr. Growth %	-13.23	102.37	-13.17	-1.62	-9.33
EBITA, 1 Yr. Growth %	-13.25	102.17	-12.73	-2.13	-9.36
EBIT, 1 Yr. Growth %	-12.33	93.57	-11.92	-1.44	-9.11
Earnings From Cont. Operations, 1 Yr. Growth %	-12.27	55.58	-7.99	-13.42	-6.32
Net Income, 1 Yr. Growth %	-12.27	55.58	-9.77	-12.97	-6.8
Normalized Net Income, 1 Yr. Growth %	-8.08	97.04	-10.96	-0.98	-11.26
Diluted EPS Before Extra, 1 Yr. Growth %	-	-	-	-	-95.12
Accounts Receivable, 1 Yr. Growth %	24	-18.54	9.95	4.68	-22.37
Inventory, 1 Yr. Growth %	30.67	76.13	43.35	30.82	12.58
Net Property, Plant and Equip., 1 Yr. Growth %	-4.65	156.13	-2.13	-1.47	-16.27
Total Assets, 1 Yr. Growth %	17.67	24.33	-10.91	6.98	5.24
Tangible Book Value, 1 Yr. Growth %	-58.18	54.73	109.2	-34.38	-26.14
Common Equity, 1 Yr. Growth %	91.97	-32.5	-105.66	-855.1	46.85
Cash From Operations, 1 Yr. Growth %	-25.32	128.89	-5.34	0.42	-11.61
Capital Expenditures, 1 Yr. Growth %	-	-14.29	1.18T	-	-
Levered Free Cash Flow, 1 Yr. Growth %	-21.84	118.68	-7.27	4.04	13.49
Unlevered Free Cash Flow, 1 Yr. Growth %	-24.22	95.33	14.73	29.95	-25.68
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	45.78	-13.36	12.87	50.06	-1.12
Gross Profit, 2 Yr. CAGR %	31.99	1.09	26.37	96.42	-1.03
EBITDA, 2 Yr. CAGR %	-10.23	28.67	32.56	-7.58	-5.55
EBITA, 2 Yr. CAGR %	-9.48	28.6	32.83	-7.58	-5.82
EBIT, 2 Yr. CAGR %	-8.8	26.81	30.57	-6.83	-5.35
Earnings From Cont. Operations, 2 Yr. CAGR %	2.55	16.83	19.64	-10.75	-9.94
Net Income, 2 Yr. CAGR %	2.55	16.83	18.47	-11.39	-9.94
Normalized Net Income, 2 Yr. CAGR %	-2.32	31.72	32.44	-6.1	-6.26
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-	-	-
Accounts Receivable, 2 Yr. CAGR %	45.16	0.5	-5.36	7.28	-9.85
Inventory, 2 Yr. CAGR %	-8.76	51.71	58.9	36.94	21.36
Net Property, Plant and Equip., 2 Yr. CAGR %	-5.66	56.28	58.32	-1.8	-9.17
Total Assets, 2 Yr. CAGR %	2.17	20.95	5.24	-2.38	6.11
Tangible Book Value, 2 Yr. CAGR %	-47.94	-19.56	79.92	17.16	-30.38
Common Equity, 2 Yr. CAGR %	78.76	13.83	-80.46	-34.63	232.99
Cash From Operations, 2 Yr. CAGR %	-18.02	30.75	47.2	-2.5	-5.79
Capital Expenditures, 2 Yr. CAGR %	3.56	-	231.66	-	-54.42
Levered Free Cash Flow, 2 Yr. CAGR %	-22.77	25.46	42.4	-1.78	8.67
Unlevered Free Cash Flow, 2 Yr. CAGR %	-17.57	17.23	49.7	22.1	-1.73
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	29.1	-0.62	27.45	1.32	39.19
Gross Profit, 3 Yr. CAGR %	97.82	-17.02	71.82	7.47	69.41
EBITDA, 3 Yr. CAGR %	20.71	15.42	12.86	20.01	-8.17
EBITA, 3 Yr. CAGR %	19.26	16.03	13.01	19.97	-8.18
EBIT, 3 Yr. CAGR %	22.58	15.12	12.3	18.89	-7.59
Earnings From Cont. Operations, 3 Yr. CAGR %	15.45	17.84	7.89	7.41	-9.3
Net Income, 3 Yr. CAGR %	15.45	17.84	7.18	6.9	-9.88
Normalized Net Income, 3 Yr. CAGR %	30.42	21.67	15.6	20.21	-7.85
Accounts Receivable, 3 Yr. CAGR %	64.93	19.73	3.56	-2.13	-3.68
Inventory, 3 Yr. CAGR %	10.31	13.6	48.87	48.93	28.29
Net Property, Plant and Equip., 3 Yr. CAGR %	-17.87	31.61	33.7	35.17	-6.88
Total Assets, 3 Yr. CAGR %	-0.6	9.08	9.23	5.82	0.1
Tangible Book Value, 3 Yr. CAGR %	-30.6	-25.15	10.62	28.54	0.46
Common Equity, 3 Yr. CAGR %	-0.11	29.2	-58.15	-33.93	-14.39
Cash From Operations, 3 Yr. CAGR %	15.85	15.44	17.4	29.58	-5.64
Capital Expenditures, 3 Yr. CAGR %	-	-2.77	-	-	38.67
Levered Free Cash Flow, 3 Yr. CAGR %	186.5	6.3	13.43	28.26	3.07
Unlevered Free Cash Flow, 3 Yr. CAGR %	163.84	7.2	16.39	42.8	3.48
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	88.83	98.26	22.35	17.19	15.14
Gross Profit, 5 Yr. CAGR %	95.09	-22.41	65.99	17.12	37.8
EBITDA, 5 Yr. CAGR %	-	22.68	23.85	5.6	5.1
EBITA, 5 Yr. CAGR %	36.92	22.62	23.06	5.93	5.06
EBIT, 5 Yr. CAGR %	39.21	23.72	24.37	5.78	4.88
Earnings From Cont. Operations, 5 Yr. CAGR %	47.13	28.98	17.11	5.44	0.37
Net Income, 5 Yr. CAGR %	44.81	28.98	16.65	5.14	-0.02
Normalized Net Income, 5 Yr. CAGR %	12.66	28.16	30.1	9.69	6.3
Accounts Receivable, 5 Yr. CAGR %	77	221.66	32.07	14.59	-2.03
Inventory, 5 Yr. CAGR %	-	64.02	27.65	22.42	37.19
Net Property, Plant and Equip., 5 Yr. CAGR %	-	14.37	6.79	17.06	14.54
Total Assets, 5 Yr. CAGR %	41.98	71.76	1.69	4.34	7.97
Tangible Book Value, 5 Yr. CAGR %	-28.62	35.09	1.59	-10.46	-8.09
Common Equity, 5 Yr. CAGR %	-14.88	36.46	-47.99	-1.62	-4.06
Cash From Operations, 5 Yr. CAGR %	73.92	19.39	27.5	7.9	7.51
Capital Expenditures, 5 Yr. CAGR %	-	-43.5	-	-	-
Levered Free Cash Flow, 5 Yr. CAGR %	-	8.1	113.07	2.99	11.5
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	8.18	107.22	12.93	8.77